-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, March 23, Chinese medicinal materials, prices have risen again
Prices of medicinal materials have generally risen
Recently, the market prices of Chinese medicinal materials have generally risen.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
(Image source: CCTV Finance)
Medicinal material dealers in the Bozhou medicinal material market said that the prices of bulk medicinal materials such as angelica and scutellariae are much higher than last year.
In the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
In the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
However, the prices of medicinal materials are affected by many factors, and it is more difficult to predict the rise or fall.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
In fact, in addition to the Bozhou medicinal material market, there are also many varieties of Anguo Medicine that are on the rise.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
(Source: Chinese Medicine World Net)
It is understood that the main factors affecting the price of medicinal materials are insufficient inventory, weather and rain, and customs control.
For example, the price of white peony in the Bozhou medicinal material market has risen because the price of white peony has continued to fall in recent years, and the enthusiasm of growers has been significantly reduced.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
A CCTV reporter learned from the Bozhou Pharmaceutical Development and Promotion Bureau that according to the local white peony planting area in 2019, its annual output should reach 100,000 tons, but the actual mining output is only 80,000 tons.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
In addition, patchouli due to heavy rain last year, and the roots of patchouli were not drained in time, resulting in poor quality of medicinal materials and low yields.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
Southeast Asian varieties such as cardamom and black pepper have not yet recovered due to the impact of import and export, and the supply exceeds demand and prices have risen.
The impact of the new pharmacopoeia on the industry
In fact, CCTV reported a general increase in the prices of Chinese medicinal materials two months ago.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
The new version of the Pharmacopoeia has raised the quality requirements for many varieties, especially the heavy metal content and pesticide residues of drugs, which directly led to the increase in the price of medicinal materials that meet the standards.
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
The industry believes that the standards of the new pharmacopoeia put forward higher requirements for related companies .
Any of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Any of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Enterprises should increase their attention to the construction of Chinese medicinal material breeding bases.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
The new pharmacopoeia's improvement of the quality standards of Chinese medicines may stimulate the price of Chinese medicinal materials in a short period of time, but in the long run, the implementation of stricter quality standards will undoubtedly regulate the healthier development of the entire Chinese medicinal materials .
It is understood that the current Chinese medicine decoction pieces market has a scale of more than 200 billion yuan, but there are probably more than a thousand Chinese medicine decoction pieces processing companies, and the market share of leading enterprises is not high.
High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
In addition, the publication of higher standards of the new version of the Pharmacopoeia is also conducive to the development of medicinal materials e-commerce.
The chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
The chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
At present, the development of my country's decoction pieces market is still immature, and high standards will cause a certain degree of change in the market, but after this process, it will be beneficial to the development of the medicinal material market.
Medical News, March 23, Chinese medicinal materials, prices have risen again
Prices of medicinal materials have generally risen
Recently, the market prices of Chinese medicinal materials have generally risen.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
(Image source: CCTV Finance)
Medicinal material dealers in the Bozhou medicinal material market said that the prices of bulk medicinal materials such as angelica and scutellariae are much higher than last year.
In the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
In the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
However, the prices of medicinal materials are affected by many factors, and it is more difficult to predict the rise or fall.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
In fact, in addition to the Bozhou medicinal material market, there are also many varieties of Anguo Medicine that are on the rise.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
(Source: Chinese Medicine World Net)
It is understood that the main factors affecting the price of medicinal materials are insufficient inventory, weather and rain, and customs control.
For example, the price of white peony in the Bozhou medicinal material market has risen because the price of white peony has continued to fall in recent years, and the enthusiasm of growers has been significantly reduced.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
A CCTV reporter learned from the Bozhou Pharmaceutical Development and Promotion Bureau that according to the local white peony planting area in 2019, its annual output should reach 100,000 tons, but the actual mining output is only 80,000 tons.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
In addition, patchouli due to heavy rain last year, and the roots of patchouli were not drained in time, resulting in poor quality of medicinal materials and low yields.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
Southeast Asian varieties such as cardamom and black pepper have not yet recovered due to the impact of import and export, and the supply exceeds demand and prices have risen.
The impact of the new pharmacopoeia on the industry
In fact, CCTV reported a general increase in the prices of Chinese medicinal materials two months ago.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
The new version of the Pharmacopoeia has raised the quality requirements for many varieties, especially the heavy metal content and pesticide residues of drugs, which directly led to the increase in the price of medicinal materials that meet the standards.
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
The industry believes that the standards of the new pharmacopoeia put forward higher requirements for related companies .
Any of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Any of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Enterprises should increase their attention to the construction of Chinese medicinal material breeding bases.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
The new pharmacopoeia's improvement of the quality standards of Chinese medicines may stimulate the price of Chinese medicinal materials in a short period of time, but in the long run, the implementation of stricter quality standards will undoubtedly regulate the healthier development of the entire Chinese medicinal materials .
It is understood that the current Chinese medicine decoction pieces market has a scale of more than 200 billion yuan, but there are probably more than a thousand Chinese medicine decoction pieces processing companies, and the market share of leading enterprises is not high.
High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
In addition, the publication of higher standards of the new version of the Pharmacopoeia is also conducive to the development of medicinal materials e-commerce.
The chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
The chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
At present, the development of my country's decoction pieces market is still immature, and high standards will cause a certain degree of change in the market, but after this process, it will be beneficial to the development of the medicinal material market.
Medical News, March 23, Chinese medicinal materials, prices have risen again
Prices of medicinal materials have generally risen
Prices of medicinal materials have generally risen Recently, the market prices of Chinese medicinal materials have generally risen.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
According to CCTV Finance, the price increase of Chinese medicinal materials has accelerated after the Spring Festival.
(Image source: CCTV Finance)
Medicinal material dealers in the Bozhou medicinal material market said that the prices of bulk medicinal materials such as angelica and scutellariae are much higher than last year.
In the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
Medicine, medicine, medicineIn the past, the best medicinal materials can be sold for more than 30 yuan, which is nearly 20 yuan per catty.
Doubled.
In addition, niche medicines have also risen a lot.
Jiang Dayong, a medicinal material dealer, said that Wang Buliu, which used to cost 67 yuan a catty, has doubled its price and sold for more than 12 yuan.
And Chu Shizi, who used to be 12 yuan a catty, now costs more than 30 yuan a catty.
However, the prices of medicinal materials are affected by many factors, and it is more difficult to predict the rise or fall.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
Sales staff are cautious in purchasing.
At the same time, buyers are also shopping around and are not easy to sell.
In fact, in addition to the Bozhou medicinal material market, there are also many varieties of Anguo Medicine that are on the rise.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
For example, grass fruit, turmeric, black pepper, white cardamom and so on.
(Source: Chinese Medicine World Net)
It is understood that the main factors affecting the price of medicinal materials are insufficient inventory, weather and rain, and customs control.
For example, the price of white peony in the Bozhou medicinal material market has risen because the price of white peony has continued to fall in recent years, and the enthusiasm of growers has been significantly reduced.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
Many farmers who originally planted white peony have adopted measures to replant or delay mining.
Insufficiency, eventually ushered in price increases.
A CCTV reporter learned from the Bozhou Pharmaceutical Development and Promotion Bureau that according to the local white peony planting area in 2019, its annual output should reach 100,000 tons, but the actual mining output is only 80,000 tons.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
Liao Zirong, deputy director of the Bozhou Pharmaceutical Development and Promotion Bureau of Huibo City, said that this is because the growers and large households could harvest this year because of the price, but a small part may want to wait until next year to harvest.
In addition, patchouli due to heavy rain last year, and the roots of patchouli were not drained in time, resulting in poor quality of medicinal materials and low yields.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
It has more than doubled from 15,000 yuan per ton last year to 38,000 yuan.
Southeast Asian varieties such as cardamom and black pepper have not yet recovered due to the impact of import and export, and the supply exceeds demand and prices have risen.
The impact of the new pharmacopoeia on the industry
The impact of the new pharmacopoeia on the industry In fact, CCTV reported a general increase in the prices of Chinese medicinal materials two months ago.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
This is due to the previous release of the 2020 version of the Pharmacopoeia jointly by the Food and Drug Administration and the Health Commission.
The new version of the Pharmacopoeia has raised the quality requirements for many varieties, especially the heavy metal content and pesticide residues of drugs, which directly led to the increase in the price of medicinal materials that meet the standards.
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
Wang Weiquan, chairman of the Chinese Medicinal Materials Planting and Cultivation Professional Committee of the China Association of Chinese Medicine, told CCTV reporters that “the price of ginseng with high pesticide residues is about 120 yuan per kilogram, but the price of low-residual or non-disabled ginseng that meets the pharmacopoeia standards is approaching.
About 200 yuan a catty.
"
The industry believes that the standards of the new pharmacopoeia put forward higher requirements for related companies .
Any of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Enterprise business enterpriseAny of the pesticide residues and heavy metals of Chinese herbal medicines that do not meet the requirements will be classified as inferior drugs or herbal medicines that do not meet the requirements of the pharmacopoeia.
This will undoubtedly quickly eliminate some unqualified raw materials of Chinese herbal medicines and force companies to pay more attention to raw materials.
Control of the source.
Enterprises should increase their attention to the construction of Chinese medicinal material breeding bases.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
Standardized planting and breeding may not be beneficial in the short term.
However, this is not only a benefit to the enterprise, but also a promotion to the entire society and the industry.
Direction to work hard.
The new pharmacopoeia's improvement of the quality standards of Chinese medicines may stimulate the price of Chinese medicinal materials in a short period of time, but in the long run, the implementation of stricter quality standards will undoubtedly regulate the healthier development of the entire Chinese medicinal materials .
Healthy, healthy, healthy It is understood that the current Chinese medicine decoction pieces market has a scale of more than 200 billion yuan, but there are probably more than a thousand Chinese medicine decoction pieces processing companies, and the market share of leading enterprises is not high.
High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
pharmnet. High standards will eliminate a number of non- pharmnet.
com.
cn/" target="_blank">regulatory norm production of small businesses, for enterprises is favorable.
It is conducive to the standardized development of the market and the increase in concentration.
com.
cn/" target="_blank">Regulationspharmnet.
com.
cn/" target="_blank"> and regulations
In addition, the publication of higher standards of the new version of the Pharmacopoeia is also conducive to the development of medicinal materials e-commerce.
The chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
Herbs medicinal herbsThe chairman of Guangdong Dongfuxing Company previously stated to Zhengdian Finance that after the 20th edition of the Pharmacopoeia is issued, all e-commerce companies will accurately publish third-party inspection reports on the product’s properties, appearance, and traceability system to the online.
This is for e-commerce companies.
A new challenge and a leap, but achieving this standard will also be a great breakthrough for the development of e-commerce.
At present, the development of my country's decoction pieces market is still immature, and high standards will cause a certain degree of change in the market, but after this process, it will be beneficial to the development of the medicinal material market.
